Skip to main content

Satellos Bioscience Inc.

corporate_fare Company Profile

Satellos Bioscience Inc.

MSLE·NASDAQ·Life Sciences·CIK 0001421642

Satellos Bioscience Inc. is a clinical-stage drug development company focused on restoring natural muscle repair and regeneration for degenerative muscle diseases. The company operates in Canada, the United States, and Australia. Satellos utilizes its proprietary discovery platform, MyoReGenX, which is an automated microscopy system designed to replicate the muscle stem cell environment outside of a living organism. Its primary drug candidate is SAT-3247, an oral, small molecule drug currently being developed to treat Duchenne muscular dystrophy disease. The company holds a license agreement with the Ottawa Hospital Research Institute (OHRI) and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc. (NASDAQ:MSLE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for MSLE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for MSLE spans 6-K, 40-F.

Recent high-impact activity:

  • Satellos Posts Q3 Loss of $11.2M, $53.0M Cash Through 2027, Health Canada Clears FSHD CTA
  • Satellos Switches BASECAMP Primary Endpoint to MRI Fat Fraction After FDA Feedback
  • Satellos Completes BASECAMP Phase 2 Enrollment, Delays Topline Data to Q1 2027
  • Satellos Gets FDA Clearance to Test Forazapadin in FSHD, Secures $5M Non-Dilutive Funding
  • Satellos Reports Q2 2026 Loss of $11.7M, Cash Runway Through 2027, and Positive TRAILHEAD Data

Short Interest & Short Volume

3.86 days to cover

FINRA reported short interest of 127,108 shares in MSLE as of the October 30, 2026 settlement, a 30.7% increase from the prior period — about 3.9 days to cover at its recent average daily volume. On November 20, 2026, 39.0% of MSLE volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)127,108 shares as of October 30, 2026
Change vs prior period▲ 30.7%
Days to cover3.86 at avg daily volume of 32,942
Daily short volume (FINRA facilities)39.0% of 57,128 shares on November 20, 2026
5-day average short volume35.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

MSLE files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with M →
$5.68
52-week range · as of 2026-11-12 $5.44 – $144
Market cap
$120.51M
Volume
113.9K (2.1× avg)
3-mo avg 53.5K
Live data · 2026-11-21 14:11 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MSLE - Latest Insights

MSLE
Nov 12, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $6.88
Real-time Price: $5.68 info
Change: -$1.20 (-17%) info
Market Cap: $120.509M info
MSLE
Nov 06, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $5.68 info
Change: -$0.320 (-5%) info
Market Cap: $120.509M info
MSLE
Sep 30, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $8.60
Real-time Price: $5.68 info
Change: -$2.92 (-34%) info
Market Cap: $120.509M info
MSLE
Sep 24, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $8.91
Real-time Price: $5.68 info
Change: -$3.23 (-36%) info
Market Cap: $120.509M info
MSLE
Aug 13, 2026, 5:03 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.82
Real-time Price: $5.68 info
Change: -$4.14 (-42%) info
Market Cap: $120.509M info
MSLE
Jul 08, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $8.37
Real-time Price: $5.68 info
Change: -$2.69 (-32%) info
Market Cap: $120.509M info
MSLE
Jul 08, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $8.37
Real-time Price: $5.68 info
Change: -$2.69 (-32%) info
Market Cap: $120.509M info
MSLE
Jun 29, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $7.00
Real-time Price: $5.68 info
Change: -$1.32 (-19%) info
Market Cap: $120.509M info
MSLE
Jun 29, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $7.50
Real-time Price: $5.68 info
Change: -$1.82 (-24%) info
Market Cap: $120.509M info
MSLE
Jun 25, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.62
Real-time Price: $5.68 info
Change: +$0.060 (+1%) info
Market Cap: $120.509M info
MSLE
May 15, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $7.17
Real-time Price: $5.68 info
Change: -$1.49 (-21%) info
Market Cap: $120.509M info
MSLE
Mar 27, 2026, 8:24 AM EDT
Filing Type: 40-F
Importance Score:
9
Price at Filing: $6.93
Real-time Price: $5.68 info
Change: -$1.25 (-18%) info
Market Cap: $120.509M info
MSLE
Mar 27, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.93
Real-time Price: $5.68 info
Change: -$1.25 (-18%) info
Market Cap: $120.509M info
MSLE
Mar 10, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $11.84
Real-time Price: $5.68 info
Change: -$6.16 (-52%) info
Market Cap: $120.509M info
MSLE
Feb 24, 2026, 7:15 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $11.07
Real-time Price: $5.68 info
Change: -$5.39 (-49%) info
Market Cap: $120.509M info
MSLE
Feb 18, 2026, 2:02 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $5.68 info
Change: -$5.55 (-49%) info
Market Cap: $120.509M info
MSLE
Feb 17, 2026, 3:22 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $11.50
Real-time Price: $5.68 info
Change: -$5.82 (-51%) info
Market Cap: $120.509M info
MSLE
Feb 12, 2026, 7:15 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $11.64
Real-time Price: $5.68 info
Change: -$5.96 (-51%) info
Market Cap: $120.509M info
MSLE
Feb 09, 2026, 7:47 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $11.50
Real-time Price: $5.68 info
Change: -$5.82 (-51%) info
Market Cap: $120.509M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets